Log In
BCIQ
Print this Print this
 

Morphomer Tau

  Manage Alerts
Collapse Summary General Information
Company AC Immune S.A.
DescriptionInhibits aggregation of Tau to neurofibrilary tangles
Molecular Target Microtubule-associated protein tau (tau) (MAPT) (FTDP-17)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentDiscovery
Standard IndicationAlzheimer's disease (AD)
Indication DetailsTreat Alzheimer's disease (AD)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today